Results 1 to 10 of about 11,791 (220)

Tofacitinib for refractory uveitis and scleritis

open access: yesAmerican Journal of Ophthalmology Case Reports, 2019
Purpose: To report the successful use of tofacitinib in the treatment of refractory uveitis and scleritis. Observations: Two patients, one with scleritis and another with anterior and intermediate uveitis, presented with refractory disease after failure ...
Michael A Paley, Jonathan J Miner
exaly   +3 more sources

Clinical profile, treatment, and visual outcome of scleritis: A single ophthalmologist experience

open access: yesOman Journal of Ophthalmology, 2022
PURPOSE: The purpose of this study was to analyze the clinical profile of patients with scleritis managed by a single ophthalmologist in a tertiary eye care center. METHODS: This was a retrospective analysis of 107 eyes of 96 patients with scleritis from
Kowsigan Magesan   +3 more
doaj   +1 more source

Scleritis and sclerokeratitis associated with IgA vasculitis: A case series

open access: yesAmerican Journal of Ophthalmology Case Reports, 2021
Purpose: To describe a case series of scleritis associated with IgA vasculitis (IgAV) at a tertiary referral center. Observations: Three men with scleritis associated with IgAV were identified: one with anterior scleritis alone, one with anterior ...
I. Hernanz   +6 more
doaj   +1 more source

Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia [PDF]

open access: yesInternational Journal of Ophthalmology, 2015
To describe the clinical features, systemic associations, treatment and visual outcomes in Saudi patients with scleritis. A retrospective chart review was performed for patients with scleritis presenting to two tertiary care eye hospitals in Riyadh,
Mohammad Al Barqi   +2 more
doaj   +1 more source

Health system wide “big data” analysis of rheumatologic conditions and scleritis

open access: yesBMC Ophthalmology, 2021
Background The development of scleritis in the setting of autoimmune conditions has been well documented. Prior series have assessed the relationship between systemic autoimmune disorders and scleritis only in patients referred for rheumatologic or ...
Meghan K. Berkenstock, Andrew R. Carey
doaj   +1 more source

Scleritis in rheumatoid arthritis: Before and during biologic era

open access: yesFrontiers in Ophthalmology, 2023
ObjectivesScleritis represents a severe extra-articular manifestation of rheumatoid arthritis (RA). Recent clinical observations suggest a decreasing incidence of scleritis in RA, attributed to improved treatment options.
Daphne P. C. Vergouwen   +5 more
doaj   +1 more source

A sore red eye with systemic involvement [PDF]

open access: yes, 2010
The study of happiness has long been a playground for philosophical speculation. By lack of empirical measures of happiness, it was not possible to check propositions about the matter.
Lightman, SL   +3 more
core   +2 more sources

Characteristics and Outcomes of Patients with Scleritis in the IRIS® Registry (Intelligent Research in Sight) Database

open access: yesOphthalmology Science, 2022
Purpose: To report patient characteristics and factors associated with poor visual acuity and abnormal intraocular pressure (IOP) in patients with scleritis in the American Academy of Ophthalmology’s IRIS® Registry (Intelligent Research in Sight). Design:
Karen R. Armbrust, MD, PhD   +1 more
doaj   +1 more source

Non-Infectious Scleritis and Systemic Collagen Vascular Disease Association

open access: yesSiriraj Medical Journal, 2020
Objective: To evaluate scleritis type in association with a systemic collagen vascular disease and the clinical characteristics of patients presenting with non-infectious scleritis.
Sutasinee Boonsopon   +4 more
doaj   +1 more source

Rituximab for non-infectious Uveitis and Scleritis

open access: yesJournal of Ophthalmic Inflammation and Infection, 2021
Purpose To provide a comprehensive review of rituximab use for the treatment of non-infectious uveitis and scleritis. Methods Review of literature through December 2020.
Caleb C. Ng   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy